Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Ildong Pharmaceutical Co., Ltd.
  6. Financials
    A249420   KR7249420001

ILDONG PHARMACEUTICAL CO., LTD.

(A249420)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Valuation
Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization1 372 966505 258463 622379 499449 542799 187
Enterprise Value (EV)1 483 401595 354516 389454 862530 235870 661
P/E ratio 11,2x24,2x36,5x-28,2x-34,6x-8,02x
Yield 1,58%-1,96%---
Capitalization / Revenue 1,85x1,10x0,92x0,73x0,80x1,43x
EV / Revenue 2,40x1,29x1,02x0,88x0,94x1,55x
EV / EBITDA 21,7x13,6x10,2x17,2x16,0x-34,7x
Price to Book 1,26x1,61x1,59x1,50x1,77x5,23x
Nbr of stocks (in thousands) 23 80623 80523 80523 79023 78523 785
Reference price (KRW) 15 66721 22419 47615 95218 90033 600
Announcement Date 03/16/201703/14/201903/12/202003/18/202103/17/202203/17/2022
1 KRW in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales1 201 344460 651503 907517 468561 845560 132
EBITDA1 22 29143 80750 75526 37633 192-25 101
Operating profit (EBIT)1 14 79225 36127 155-1 5425 529-54 412
Operating Margin 7,35%5,51%5,39%-0,30%0,98%-9,71%
Pre-Tax Profit (EBT)1 14 01420 42216 438-22 634-9 724-141 205
Net income1 12 57919 84112 721-13 444-13 019-99 705
Net margin 6,25%4,31%2,52%-2,60%-2,32%-17,8%
EPS2 1 395876534-565-547-4 192
Dividend per Share2 247-381---
Announcement Date 03/16/201703/14/201903/12/202003/18/202103/17/202203/17/2022
1 KRW in Million
2 KRW
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2019 Q4 2020 Q1 2020 Q2
Net sales1 122139137
EBITDA1 -5,5914,2
Operating profit (EBIT)1 -7,54-1,297,22
Operating Margin -6,17%-0,93%5,26%
Pre-Tax Profit (EBT) ---
Net income ---
Net margin ---
EPS ---
Dividend per Share ---
Announcement Date 02/14/202005/07/202008/13/2020
1 KRW in Billions
Balance Sheet Analysis
Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt1 110 43590 09652 76875 36280 69271 474
Net Cash position1 ------
Leverage (Debt / EBITDA) 4,95x2,06x1,04x2,86x2,43x-2,85x
Free Cash Flow -17 86346 32228 990-1 447101 154
ROE (Net Profit / Equities) -7,18%4,53%-5,08%-5,13%-47,9%
Shareholders' equity1 -276 361280 568264 862253 720208 118
ROA (Net Profit / Asset) -2,85%3,01%-0,16%0,57%-5,18%
Assets1 -697 376422 9388 212 330-2 294 5291 926 596
Book Value Per Share2 12 40613 14212 21710 63010 7026 429
Cash Flow per Share2 9201 8463 3513 7813 5975 701
Capex1 8 27516 73015 08812 06014 35214 626
Capex / Sales 4,11%3,63%2,99%2,33%2,55%2,61%
Announcement Date 03/16/201703/14/201903/12/202003/18/202103/17/202203/17/2022
1 KRW in Million
2 KRW
Key data
Capitalization (KRW) 1 187 928 675 900
Capitalization (USD) 932 967 357
Net sales (KRW) 560 131 626 310
Net sales (USD) 439 912 373
Number of employees 1 385
Sales / Employee (KRW) 404 427 167
Sales / Employee (USD) 317 626
Free-Float 58,9%
Free-Float capitalization (KRW) 699 678 251 218
Free-Float capitalization (USD) 549 508 554
Avg. Exchange 20 sessions (KRW) 109 741 813 150
Avg. Exchange 20 sessions (USD) 86 188 280
Average Daily Capital Traded 9%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA